1. Home
  2. TLSA vs SY Comparison

TLSA vs SY Comparison

Compare TLSA & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • SY
  • Stock Information
  • Founded
  • TLSA 2013
  • SY 2013
  • Country
  • TLSA United Kingdom
  • SY China
  • Employees
  • TLSA N/A
  • SY N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • SY EDP Services
  • Sector
  • TLSA Health Care
  • SY Technology
  • Exchange
  • TLSA Nasdaq
  • SY Nasdaq
  • Market Cap
  • TLSA 187.0M
  • SY N/A
  • IPO Year
  • TLSA 2000
  • SY 2019
  • Fundamental
  • Price
  • TLSA $1.45
  • SY $3.80
  • Analyst Decision
  • TLSA
  • SY Strong Buy
  • Analyst Count
  • TLSA 0
  • SY 1
  • Target Price
  • TLSA N/A
  • SY $5.50
  • AVG Volume (30 Days)
  • TLSA 246.7K
  • SY 3.3M
  • Earning Date
  • TLSA 07-22-2025
  • SY 08-22-2025
  • Dividend Yield
  • TLSA N/A
  • SY 0.68%
  • EPS Growth
  • TLSA N/A
  • SY N/A
  • EPS
  • TLSA N/A
  • SY N/A
  • Revenue
  • TLSA N/A
  • SY $199,226,349.00
  • Revenue This Year
  • TLSA N/A
  • SY N/A
  • Revenue Next Year
  • TLSA N/A
  • SY $2.44
  • P/E Ratio
  • TLSA N/A
  • SY N/A
  • Revenue Growth
  • TLSA N/A
  • SY N/A
  • 52 Week Low
  • TLSA $0.63
  • SY $0.66
  • 52 Week High
  • TLSA $1.91
  • SY $4.84
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 48.43
  • SY 68.61
  • Support Level
  • TLSA $1.43
  • SY $1.60
  • Resistance Level
  • TLSA $1.81
  • SY $4.84
  • Average True Range (ATR)
  • TLSA 0.09
  • SY 0.69
  • MACD
  • TLSA -0.02
  • SY 0.14
  • Stochastic Oscillator
  • TLSA 18.53
  • SY 66.07

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: